Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$156.00 USD

156.00
1,592,815

+0.78 (0.50%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $155.96 -0.04 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (46 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Cardinal Health (CAH) Tops Q1 Earnings, Misses on Sales

by Zacks Equity Research

Cardinal Health's (CAH) pharmaceutical segment revenues increased in the first quarter due to strong growth from the Specialty business and higher number of Pharmaceutical Distribution business customers.

    Zacks Equity Research

    What's in Store for Cardinal Health (CAH) in Q1 Earnings?

    by Zacks Equity Research

    Cardinal Health (CAH), a global player in the healthcare services and products space, has been grappling with pricing deflation in the generics segment in the first quarter.

      Zacks Equity Research

      Why Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report?

      by Zacks Equity Research

      Cardinal Health (CAH) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

        Zacks Equity Research

        Cardinal Health (CAH) Beats on Earnings & Revenues in Q4

        by Zacks Equity Research

        Cardinal Health (CAH) reported strong fourth quarter results, beating the Zacks consensus estimate on both counts. Solid growth in the company's Pharmaceutical and Medical segments were the key catalysts.

          Zacks Equity Research

          Cardinal Health (CAH) Tops Q3 Earnings, Miss on Revenues

          by Zacks Equity Research

          Cardinal Health???s adjusted earnings rose 7% on a year-over-year basis to $1.53 per share.

            Zacks Equity Research

            Medical Product Stocks' Earnings Due on May 1: CAH & OCPNY

            by Zacks Equity Research

            Here we take a look at two major Medical Product bigwigs, which are expected to release their earnings results on May 1.

              Zacks Equity Research

              Why Cardinal Health (CAH) Might Surprise This Earnings Season

              by Zacks Equity Research

              Cardinal Health (CAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                Zacks Equity Research

                Why Is Cardinal Health (CAH) Up 4.4% Since the Last Earnings Report?

                by Zacks Equity Research

                Cardinal Health (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                  Zacks Equity Research

                  Cardinal Health (CAH) Q2 Earnings Beat Estimates, Rise Y/Y

                  by Zacks Equity Research

                  Cardinal Health Inc. (CAH) reported second-quarter fiscal 2017 adjusted earnings of $1.34 per share, which beat the Zacks Consensus Estimate of $1.24 and increased 3% on a year-over-year basis.

                    Zacks Equity Research

                    Cardinal Health (CAH) Tops Q2 Earnings, Miss on Revenues

                    by Zacks Equity Research

                    Cardinal Health???s adjusted earnings rose 3% on a year-over-year basis to $1.34 per share.

                      Tracey Ryniec headshot

                      Start the Week with These Perfect Earnings Charts

                      by Tracey Ryniec

                      Who's been able to beat earnings every quarter for 5 years?

                        Zacks Equity Research

                        Cardinal Health (CAH) Q2 Earnings: What's in the Cards?

                        by Zacks Equity Research

                        Cardinal Health (CAH), a global player in the healthcare services and products space, is set to report second-quarter fiscal 2017 results on Feb 7, before the bell.

                          Zacks Equity Research

                          McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?

                          by Zacks Equity Research

                          McKesson Corporation (MCK), one of the largest healthcare services providers, is scheduled to report third-quarter fiscal 2017 results on Jan 25.

                            Zacks Equity Research

                            Should Value Investors Pick Cardinal Health (CAH)?

                            by Zacks Equity Research

                            Cardinal Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.

                              Mark Vickery headshot

                              Top Research Reports for November 14, 2016

                              by Mark Vickery

                              Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Berkshire Hathaway (BRK.B) and Altria (MO).

                                Zacks Equity Research

                                Company News for November 01, 2016

                                by Zacks Equity Research

                                Companies In The News are: LVLT,CTL,CAH,CHKP,DO

                                  Sheraz Mian headshot

                                  Top 3 Research Reports for August 8, 2016

                                  by Sheraz Mian

                                  Today's must-read reports are for MasterCard (MA), Bank of America. (BAC) and Kraft Heinz (KHC).